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Abstract
Using expression profiles from postmortem prefrontal cortex
samples of 624 dementia patients and non-demented controls, we
investigated global disruptions in the co-regulation of genes in
two neurodegenerative diseases, late-onset Alzheimer’s disease
(AD) and Huntington’s disease (HD). We identified networks of
differentially co-expressed (DC) gene pairs that either gained or lost
correlation in disease cases relative to the control group, with the
former dominant for both AD and HD and both patterns replicating
in independent human cohorts of AD and aging. When aligning
networks of DC patterns and physical interactions, we identified a
242-gene subnetwork enriched for independent AD/HD signatures.
This subnetwork revealed a surprising dichotomy of gained/lost
correlations among two inter-connected processes, chromatin
organization and neural differentiation, and included DNA methyl-
transferases, DNMT1 and DNMT3A, of which we predicted the former
but not latter as a key regulator. To validate the inter-connection
of these two processes and our key regulator prediction, we
generated two brain-specific knockout (KO) mice and show that
Dnmt1 KO signature significantly overlaps with the subnetwork
(P = 3.1 × 1012), while Dnmt3a KO signature does not (P = 0.017).
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Introduction
Different neurodegenerative diseases share similar dysfunctional
phenotypes, such as misfolded protein aggregates, neuronal cell
death, inflammation, and cognitive decline. Yet, the complexity of
these diseases has hindered efforts to obtain a comprehensive view
of common molecular mechanisms underlying their initiation or
propagation, and thereby hampered development of drugs that
could broadly halt neuronal loss in humans (Avila, 2010; Haass,
2010). This study focuses on two such complex diseases in humans,
Alzheimer’s and Huntington’s, for which there is currently no effec-
tive intervention to halt or reverse the associated progressive cogni-
tive decline. Late-onset Alzheimer’s disease (AD) is the most
common form of dementia, accounting for up to 70% of all cases,
and is characterized by an initial impact on memory with a subse-
quent progressive decline in cognitive functioning. The hippocam-
pus and the surrounding cortical regions are the major sites of
AD-related pathology, characterized by increasing accumulation of
amyloid-beta (Ab) plaques and tau-related neurofibrillary tangles,
both of which are major contributors to the hallmark lesions associ-
ated with this disease (Armstrong, 2009). Compared to AD,
Huntington’s disease (HD) is a rare (~ 5/100,000) neurodegenera-
tive disorder exhibiting cognitive dysfunction and severe motor
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impairments that arises as a result of dominant mutations within
the Huntingtin gene (HTT), causing expansion of a polyglutamine
region within the HTT protein (Roze et al, 2010). However, studies
show that other genes and environmental factors can modify the
expressivity of the HTT polymorphisms in HD (van Dellen &
Hannan, 2004). HD pathology features astrogliosis and neurodegen-
eration of medium spiny neurons, initially affecting the striatum and
progressively the cortices and other regions including hippocampus
(Roze et al, 2010).
Complex diseases and healthy biological systems are increasingly
modeled using a network of pairwise interactions among genes,
gene products, or biomolecules (Przytycka et al, 2010; Barabasi
et al, 2011), since analyzing the properties of the entire network or
subnetworks has the potential to rapidly generate new biological
hypotheses, such as uncovering functionally coherent gene modules
from co-expression networks (Zhang & Horvath, 2005; Oldham
et al, 2006) or novel disease genes/pathways (Horvath et al, 2006;
Chen et al, 2008; Emilsson et al, 2008; Ferrara et al, 2008). We
extend this line of research by systematically constructing and
analyzing gene dysregulatory networks and underlying molecular
interactions that are affected in common between two neurodegen-
erative diseases, and investigating whether this common network
has distinctive features not apparent in the individual disease
networks. Co-regulation of genes involved in biological pathways is
needed for the proper functioning of a cell, and disruption of these
co-regulation patterns has been observed in human diseases such as
AD (Rhinn et al, 2013; Zhang et al, 2013). Detecting such disrup-
tions through a “differential co-expression” (DC) analysis can help
us better understand the initiation and propagation of the disease-
induced disruptions among interacting genes, compared to
commonly used differential expression analysis that simply detects
genes whose expression levels change between cases and controls
(de la Fuente, 2010; Leonardson et al, 2010; Rhinn et al, 2013;
Zhang et al, 2013). We extend this advantage of DC analysis even
further by systematically searching for a molecular network of phys-
ical (protein–protein and protein–DNA) interactions that connect
the identified dysregulation patterns. This is achieved by extending
our previous DC analysis (Wang et al, 2009) and network alignment
(Narayanan & Karp, 2007) methods to identify both the shared
dysregulation patterns and the supporting molecular networks
affected in two neurodegenerative diseases.
Specifically, we assembled networks of dysregulated gene pairs
by analyzing genome-wide gene expression data collected from over
600 postmortem brain dorsolateral prefrontal cortex (DLPFC) tissues
of AD and HD patients, as well as non-dementia controls. We
focused on the DLPFC brain region as it is commonly affected in
both AD and HD (Armstrong, 2009; Roze et al, 2010), and our main
interest was to understand the common gene regulatory relation-
ships disrupted in degenerative dementia. Gene co-regulation
patterns were systematically compared between different groups,
and gene pairs whose co-regulation in DLPFC is gained (gain of co-
expression, GOC) or lost (loss of co-expression, LOC) in disease
cases relative to controls were identified and assembled into the
disease-specific differential co-expression (DC) network. Overall, we
found GOC gene pairs to be more prevalent than LOC pairs in the
DC networks of both neurodegenerative diseases; however, LOC
pairs were more consistent across both diseases. Clustering the DC
network yielded modules of genes enriched for clinical endpoints
related to brain pathology and dementia, and revealed new disease
genes like FAM59B (GAREML) that participated in LOC pairs at the
interface between modules. The AD DC network was replicated in
an independent human cohort, before or after exclusion of age-
related dysregulation, supporting the validity and robustness of the
DC network.
A systematic search for physical (protein–protein and protein–
DNA) interactions connecting the DC relations common to AD and
HD revealed a 242-gene subnetwork, which was enriched for inde-
pendent AD, HD and depression related signatures, and revealed an
interesting split of LOC/GOC dysregulations among two physically
interacting biological processes, neural differentiation and chroma-
tin organization. To test the interconnection of these processes, we
constructed two brain-specific knockout mice targeting two genes of
similar function in the subnetwork, DNMT1 and DNMT3A. We
predicted DNMT1, but not DNMT3A, as a key regulator for the
subnetwork based on the number of their interaction partners, and
consistent with our predictions, only the knockout signature of
DNMT1 in the cortex significantly overlapped with the subnetwork
genes. This result validates not only the interconnection of two
biological processes in the subnetwork but also the difference
between our key versus non-key regulator predictions in the subnet-
work. In conclusion, our results from inference and analyses of DC
networks revealed new insights into the common pathological
mechanisms in two neurodegenerative diseases.
Results
We focused on systematic changes at the molecular level in the
dorsolateral prefrontal cortex (DLPFC) from AD patients, HD
patients, and non-demented subjects, since this brain region is
commonly affected in both AD and HD (Armstrong, 2009; Roze
et al, 2010). The characteristics of the disease and control samples
obtained from HBTRC (Harvard Brain Tissue Resource Center)
are summarized in Supplementary Table S1. Briefly, 624 DLPFC
(Brodmann area 9) postmortem brain tissues were profiled on a
custom-made Agilent 44K array containing 40,638 reporters
uniquely targeting 39,909 mRNA transcripts of known and predicted
genes. We note that DLPFC tissue samples from 157 HD patients
(Supplementary Table S1) represent a significant fraction (~ 1%) of
the incidence of HD in the US. All brains were extensively pheno-
typed for neurohistopathology traits related to AD (Braak stage,
specific regional atrophy on a gross and microscopic scale, and
ventricular enlargement) or HD (Vonsattel scale severity). The signs
of neuropathology were used to confirm diagnoses of AD and HD,
as well as the lack of neuropathology in the control group. Finally,
all gene expression traits of disease and control samples were
adjusted for age, gender, and other covariates (see Materials and
methods).
Identification of dysregulated gene pairs in
neurodegenerative diseases
To compare the brain transcriptional networks in AD, HD and non-
dementia control brains, we tested for differences in the correlations
(co-expression) of all gene pairs computed in each of the groups.
Since co-expression of functionally related genes is necessary for the
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proper regulation of biological processes within a cell and coordina-
tion of several cell types that compose a tissue, mapping changes in
overall co-expression patterns in disease tissues versus controls
could provide indications on which tissue regulatory programs are
disrupted by disease. Of particular interest in identifying differen-
tially co-expressed gene pairs is the overall pattern of increasing and
decreasing correlations between the brain groups, with gain (or
loss) of co-expression, termed GOC (or LOC), indicating increasing
(or decreasing) correlation strength in the disease group compared
to the control group. For this comparison, we restricted the analysis
to DC pairs detected at a 1% false discovery rate (FDR) and that
were significantly co-expressed (either negatively or positively) in
only one of the two comparison groups (i.e., either cases or controls
for GOC or LOC pairs, respectively; see Materials and methods, and
Supplementary Dataset D1). We identified 28,223 DC gene pairs
(covering 8,897 unique reporters), whose co-expression relationship
differed significantly between the AD and non-dementia control
groups and was significant in only one of these two groups. Of these
identified DC pairs, 65.8% showed gain of co-expression (GOC) in
AD, while the rest showed a loss of co-expression (LOC) in AD
(Fig 1A and B, Table 1). As cortices are affected in HD as well (Roze
et al, 2010), we compared HD samples against non-dementia controls
to uncover 106,134 DC gene pairs, almost fourfold more pairs than in
AD (Fig 1A and B, Table 1). Figure 1C highlights an example of the
pairwise correlation between GPS2 and STARD7 showing similarly
disrupted co-expression patterns in both AD and HD.
Similar to what we observed for AD, HD was predominantly
characterized by GOC changes compared to LOC changes (Fig 1A
and Table 1), suggesting a common pattern of change in the brain
network associated with these two neurodegenerative diseases. In
fact, 8,776 gene pairs were identified as DC in both AD and HD
comparisons to controls, a highly significant overlap comprising
31% of all DC gene pairs and 74% of all DC reporters identified in
AD (P < 2.2 × 1016; Table 1). The overlapping DC pairs always
had the same type of disruption (either GOC or LOC) as the control
group is same in both comparisons. Furthermore, despite GOC being
a more common feature than LOC of the disease networks, the two
diseases shared a larger fraction of LOC than GOC gene pairs
(Fig 1B and Table 1), which suggests that the LOC changes better
reflect the neuropathology common to these diseases.
In both AD and HD comparisons to controls, DC analysis comple-
mented conventional t-statistics-based differential expression (DE)
analysis by uncovering additional disease-associated genes. For
instance, only 9.9% of the 8,897 DC reporters identified in the AD
versus controls comparison (Table 1) overlap with the 2,206 DE
reporters, even when the DE is defined using a lenient (uncorrected)
P-value cutoff of 0.05 (if we require a DC reporter to participate in
at least five DC pairs instead of the one used above, then 12.7% of
the 2,667 DC reporters are also DE; see also Supplementary Figs S1,
S2, S3, and Supplementary Text A.1). This is in line with the negligi-
ble overlap between DE and DC gene sets in peripheral blood from
experiments exploring response to feeding in humans (Leonardson
et al, 2010), and suggests that mRNA levels of several genes could
be buffered against changes in co-regulation patterns and co-regulation
patterns could be preserved at different levels of expression of the
participating genes.
Several common variants have been shown to associate with AD
based on genome-wide association studies (GWAS) catalog
(Hindorff et al, 2009), and rare variants in certain genes have also
been identified through Mendelian inheritance based on OMIM data-
base (Supplementary Table S2 and Supplementary Text A.2).
Among these 23 curated AD-related genes, the allelic effects for
APOE, GAB2, SASH1, and FAM113B related genotypes on AD risk
were replicated in the HBTRC samples, with the most likely reason
for lack of replication of other reported risk variants being lack of
power in our relatively small study group (Supplementary Table
S2). We find that nine of these 23 AD-related genes show at least
one pair of DC in AD (Table 2), and a striking majority (69%) of the
DC pairs involving these AD-causing genes showed LOC changes
(Table 2), despite the fact that 66% of all DC gene pairs in AD
exhibited GOC (Table 1 and Supplementary Text A.2). For example,
APOE was involved in 85 DC pairs, all of which were LOC (Table 2).
Polymorphism in HTT is the predominant genetic cause of HD (Roze
et al, 2010), and we find that HTT gained two co-expression rela-
tionships in HD, such as to INSR and NPY1R, which are genes with
known links to HD disturbances or progression (Supplementary
Text A.2).
As the number of partners of a gene in a transcriptional network
can provide clues on the essentiality of the gene and effect on
disease (Horvath et al, 2006), we also inspected the hub genes in a
network assembled from the DC pairs (Supplementary Fig S4A).
The top 10 hub genes (participating in the largest number of DC
pairs) in AD had each gained or lost between 144 and 244 co-expression
relations in AD compared to controls, whereas these numbers
ranged from 339 to 550 for HD versus controls (see Supplementary
Text A.3). When considering only disrupted pairs common to both
AD and HD, the top 10 hub genes in this shared DC network were
RNASE1, GSN, SLC39A11, GPS2, CSRP1, FAM59B, TIMELESS, EZR,
AMPD2, and SASH1, six of which were also in the top 10 hub genes
for AD (Supplementary Fig S5A–C). Of interest, TIMELESS gained 91
co-expression relations in common in both diseases, and circadian
rhythm disruption has been observed in both AD and HD patients
(Weldemichael & Grossberg, 2010; Kudo et al, 2011); GPS2, a
subunit of the NCOR1–HDAC3 complex involved in anti-inflammation
and lipid metabolism (Jakobsson et al, 2009; Venteclef et al, 2010),
shared 107 GOC partners between the diseases; and SASH1, which
has a known AD association (Heinzen et al, 2009), replicated in the
HBTRC samples as already noted (Supplementary Table S2) and
shared several LOC partners (more than 80% of its 149 AD, 384 HD,
and 136 shared DC pairs were LOC).
DC patterns are replicated in an independent human dataset
To examine the robustness of the identified dysregulation patterns,
we checked whether the DC patterns identified in the AD versus
controls comparison showed similar dysregulation in an indepen-
dent human cohort of late-onset AD and control individuals
(Webster et al, 2009). Frontal cortex expression data were available
for 31 AD and 40 control individuals in that study. First, the increased
number of GOC pairs compared to LOC pairs seen in the HBTRC
samples was also observed in the independent dataset at various
Q-statistics cutoff values (Fig 2A and B). Next, we checked whether
the correlations of the LOC pairs in the control group were robust
and could be replicated in the control samples of the independent
study. Of the 3,569 LOC pairs that we identified in AD and had both
transcripts in a pair represented in the independent dataset, 49.5
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and 12.2% were also correlated in the independent control samples
using Pearson’s correlation P < 0.05 before and after Bonferroni
correction, respectively (these fractions were 12.5 and 0.4%, respec-
tively, with random pairs of the same size and network connectiv-
ity, as obtained by shuffling gene labels; note that proportional test
P = 0 for both cases).
Finally, we tested whether the magnitude as well as direction of
the DC pairs identified in the HBTRC AD set replicated in the inde-
pendent data. There were 11,561 genes in common between these
datasets and an aging dataset discussed below, among which the
HBTRC AD set revealed 13,924 DC pairs at Q > 25.6 (corresponding
to FDR 1% and hereafter called the ‘HBTRC-identified’ DC pairs)
and the independent AD data yielded 5,913,175 DC pairs at
Q > 3.84 (analytical P = 0.05; we use a lenient Q cutoff for the inde-
pendent data as it has fewer samples than HBTRC data and is used
for replication and not discovery). Of the HBTRC-identified DC
pairs, 5.54% got replicated in the independent AD set in the same
GOC/LOC direction at Q > 3.84 (analytical P = 0.05). The much
smaller sample size of the independent AD set compared to the
HBTRC dataset may explain the low absolute value of this
replication rate; however, there is a clear positive trend between
signal strength in the HBTRC data and the replication rate
A
B
C
Figure 1. Categories of genome-wide, gene–gene dysregulation patterns in neurodegeneration.
Two categories of changes, gain of co-expression (GOC) and loss of co-expression (LOC), were detected in a genome-wide comparison of gene–gene co-expression relations
between neurodegenerative (AD or HD) and normal (non-demented control) brains.
A There is a greater number (y-axis) of GOC than LOC gene pairs in both AD and HD.
B Overlapping DC pairs between AD and HD show that LOC is significantly higher in the overlap compared with either disease alone.
C An example of a gene pair (GPS2 versus STARD7) whose expression variation across individuals (x- and y- axis) reveals a GOC change in both AD and HD.
Table 1. Differentially co-expressed (DC) pairs of genes identified via comparison of Alzheimer’s disease (AD) or Huntington disease (HD) samples
to control samples.
Comparison
Q-statistic cutoff
(FDR estimate)
Number of DC pairs
(number of reporters)
Number of GOC pairs
(% of all DC)
Number of LOC pairs
(% of all DC)
AD versus controls 25.6 (0.01) 28,223 (8,897) 18,560 (65.8%) 9,663 (34.2%)
HD versus controls 21.7 (0.01) 106,134 (14,428) 84,541 (79.7%) 21,593 (20.3%)
Overlap 8,776 (6,624) 4,117 (46.9%) 4,659 (53.1%)
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(i.e., DC pairs with higher Q-values in the HBTRC data are more
likely to be replicated in the independent data as shown in Fig 2C),
and this replication rate is significantly higher than that of random
pairs of the same size as the HBTRC-identified DC pairs (hypergeometric
P = 1.1 × 106). To further test the impact of network connectivity
(inter-relationship) of DC pairs on the replication rate, we randomly
selected gene pairs of the same size and network connectivity as the
HBTRC-identified DC pairs by shuffling gene labels in the indepen-
dent data and computed what fraction of them got replicated
(Fig 2C, and Supplementary Fig S6C). Repeating this procedure
1,000 times demonstrated that the replication fraction is significant
not only for the HBTRC-identified DC pairs (GOC + LOC at
P < 1/1,000), but also separately for the GOC (P < 1/1,000) and
LOC (P < 1/1,000) pairs. Replication results were similar at other Q
cutoffs (2.71 or 6.63 corresponding to analytical P = 0.1 or 0.01,
respectively) in the independent data (Supplementary Fig S6A). In
summary, our set of discoveries as a whole shows significant
replication in a cohort of AD and control samples obtained in an
external study from different brain banks and profiled using differ-
ent technologies.
Most DC patterns are not associated with age
It is worth noting that AD patients in our study are older on average
than non-dementia controls (Supplementary Table S1), raising the
question of how much age contributes to the dysregulation of
HBTRC-identified DC pairs. A neurodegenerative disease state in
general, and DC pairs in particular, could result from the normal
aging process, accelerated or premature aging induced by AD, or
age-independent pathological mechanisms, and disentangling the
effect of these factors remains open (Sperling et al, 2011) despite
some recent advances (Cao et al, 2010; Podtelezhnikov et al, 2011). To
dissect aging effects in our study, we first determined age-associated
DC pairs by comparing the expression data of neuropathology-free
postmortem samples (Colantuoni et al, 2011) of 56 elder (age
between 50 and 90 at time of death) to 53 adult (age between 20
and 40 at time of death) group of individuals. Of the HBTRC-
identified DC pairs, 32.3% were age-associated—i.e., differentially
co-expressed between the elder versus adult groups even at a lenient
cutoff of Q > 2.71 (analytical P = 0.1). Next, we repeated the repli-
cation test using the independent AD dataset as outlined above, but
after excluding any age-associated DC pair (20,333,247 DC pairs at
Q > 2.71 (analytical P = 0.1) among genes represented in all three
AD/aging datasets) from the HBTRC-identified DC pairs. The results
before or after exclusion of age-associated DC pairs were similar
both in terms of replication fraction (Fig 2C) and its significance
(P ≤ 1/1,000, 14/1,000, and 1/1,000 for DC, GOC, and LOC pairs,
respectively, using the same gene label shuffling test used above;
Supplementary Fig S6B and D). These results suggest that most
dysregulated pairs we identified in AD were not due to aging but
related to the disease itself.
Modular organization of the DC network elucidates shared
pathologies of AD and HD
With confidence that the identified DC pairs are robust, we next aim
to understand the biological processes affected by DC pairs in AD
and/or HD. Towards this, we attempted to decompose the DC
network (Supplementary Dataset D1) defined over thousands of
genes into smaller modules of genes, such that genes within each
module participated in a larger number of DC relations among them-
selves than with genes in other modules. By applying a previously
published clustering approach (Wang et al, 2009) based on spectral
techniques and a modularity score function (see Materials and meth-
ods), we detected 149 DC modules for AD (Supplementary Fig S4B)
and 220 for HD (Supplementary Dataset D2), respectively containing
more than 77% of the genes in the DC network for AD and HD.
To understand shared pathologies between AD and HD at the
module level, we examined how shared DC pairs were distributed
within or between AD modules. We first constructed a network of
AD modules by aggregating intra-module DC pairs (both genes in a
DC pair within the same module) or inter-module DC pairs (a DC
pair interfacing two modules) into weighted links between
modules (Fig 3A), and annotated each module as GOC or LOC
based on which category was dominant within the module. Among
the modules that contained a significant number of shared DC
pairs, all but three were LOC modules and they were also grouped
together with other LOC modules (Fig 3A) by Cytoscape’s ‘yFiles
Organic’ layout algorithm (www.cytoscape.org). This observation
is consistent with the shared network being mostly LOC despite
the dominance of GOC in the individual disease networks (similar
trend was also observed for the HD module network shown in
Fig 3B). In enrichment tests done systematically for each module,
shared LOC modules M1, M32 in AD, and M24 in HD were signifi-
cantly enriched for pathways related to metabolism of basic amino
acids (Fig 3 and Supplementary Tables S3 and S4), and shared
GOC module M6 in AD (along with three other modules) was
significantly enriched for genes correlated to an AD clinical
endpoint termed Braak stage, which captures the severity of the
load of neurofibrillary tangles in the HBTRC samples (Supplemen-
tary Table S5).
The overall topology of the DC module network in Fig 3 also
revealed widespread loss of co-regulation in the crosstalk (inter-
module) relationship between shared DC modules and facilitates
hypothesis on regulator genes whose disruption lies at the interface
of different modules. For instance, nine genes in the shared LOC AD
Table 2. Highlighting well-confirmed genetic causes of AD in the DC
network pertaining to AD. We tested replication of published genetic
associations to AD in the HBTRC samples and reported the odds ratio
(OR), effect allele, and association P-values adjusted for age and
gender in Supplementary Table S2.
Gene
Number of
DC gene pairs %GOC, % LOC
An example of
DC gene pair
APOE 85 0, 100 APOE–SASH1
PSEN1 23 0, 100 PSEN1–GSN
PICALM 1 100, 0 PICALM–CA394907
GAB2 3 100, 0 GAB2–MRAP
RELN 5 20, 80 RELN–NCKX3
SASH1 149 13, 87 SASH1–CST3
TTLL7 9 78, 22 TTLL7–FAM134B
BIN1 43 42, 58 BIN1–GSN
ABCA7 70 100, 0 ABCA7–NFKBIA
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module M26 exhibited loss of co-regulation with a single gene
FAM59B in the GOC AD module M39 in both diseases (Fig 4A).
FAM59B (also known as GAREML or GRB2 association, regulator of
MAPK1-like) is a gene whose function is poorly characterized;
however, its DC relationship with genes in M26 such as SLC1A2 and
GRIN2C in the glutamatergic system (whose dysfunction is involved
A
C
B
Figure 2. Replication in an independent human cohort.
A, B The prevalence of GOC over LOC pairs in AD versus controls comparison in an independent human cohort replicates a similar observation in the HBTRC samples.
Due to small sample size of the independent cohort, we classified a gene pair as GOC if its’ Spearman correlation P-value was lower in the AD group compared to
the controls and LOC otherwise (thereby relaxing the stringent GOC/LOC definition used in the HBTRC samples).
C The replication fraction of DC pairs identified in the AD versus controls HBTRC samples (denoted AD DC pairs, and shown as ‘Observed’ solid lines with dots), and
the same replication fraction after excluding any age-associated DC pair from the HBTRC DC pairs (denoted AD-Aging DC pairs, and shown as ‘Observed’ dashed
lines); only DC pairs among genes represented in all three AD/aging datasets were considered. Various cutoffs on Q were used in the HBTRC data to derive the DC
pairs (with black line indicating the chosen 1% FDR cutoff) and a cutoff of 3.84 (analytical P = 0.05) was used in the independent AD data to call when a
HBTRC-derived DC pair got replicated in the independent data (note that replication also requires the same GOC/LOC direction in both datasets, with direction
in both datasets determined as above using the Spearman correlation P-values). The replication fractions of both AD and AD-Aging DC pairs were significant
based on 1,000 gene label shufflings (see text and Supplementary Fig S6), random ten of which for the AD DC pairs are shown here as lightly shaded
‘Randomized’ lines.
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in neurodegeneration (Sanacora et al, 2008)), its hub status and DC
partners including APOE and TIMELESS in the shared DC network
(as noted above and in Supplementary Fig S5C), and its correlation
with Braak stage in our data (Fig 4B) all taken together support
FAM59B’s association with neurodegeneration.
Physical interactions mediating common disruption patterns
Transcriptional dysregulation in AD and HD could propagate along
a network of physical interactions among genes, proteins, and other
molecules. To infer such molecular interactions mediating common
disruption patterns in AD and HD, we aligned the network of 8,776
DC pairs shared between both diseases (Table 1) with a network of
physical interactions compiled from various literature-curated data-
bases such as BioGRID, BIND, MINT, HPRD (Mathivanan et al,
2006) totaling 116,220 non-redundant protein–protein, protein–
DNA, or other types of pairwise interactions among 12,951 genes.
We applied a variant of a rigorous alignment method (Narayanan &
Karp, 2007) to find connected regions of the common DC network
that were also connected in the physical network, so that disrupted
co-expression of these gene pairs was more likely to generate func-
tional consequences (see Materials and methods). The largest
aligned subnetwork found by the method comprised 242 genes
participating in 401 common DC pairs and 370 supporting physical
interactions (Fig 5A and Supplementary Dataset D3; other aligned
subnetworks were small with at most two genes). Note that these
242 genes were selected by the algorithm (see Materials and meth-
ods) from the background of 1,739 overlapping genes in the physi-
cal and common DC network, by virtue of their connectivity in the
two networks (i.e., any two of these genes could be connected by a
path involving only common AD/HD DC pairs and another involv-
ing only physical interactions). The subnetwork was significantly
enriched for GO biological processes such as neuron differentiation
(P = 8.8 × 107) and neurogenesis (P = 3.1 × 106), regulation of
cellular metabolic process (P = 1.3 × 107), gap junction trafficking
(P = 1.1 × 106), and regulation of apoptosis (P = 5.6 × 106). It
was also enriched for actin cytoskeleton complex (P = 6.3 × 107),
and cytoskeletal alterations have been implicated in the disease
progression of both AD and HD (Bonilla, 2000; Benitez-King et al,
2004).
By providing a scaffold of supporting physical interactions, the
242-gene aligned subnetwork enabled us to hypothesize how
disease-induced dysregulation among specific genes could be medi-
ated and propagated. Consider the gene GSN, which exhibits the
largest number of DC relations in this aligned network and the
second largest number of overall common DC relations (117 LOC
pairs) shared between both diseases (its immediate neighbors in the
aligned subnetwork are shown in Fig 5B). GSN encodes the cyto-
skeletal regulatory protein gelsolin, which is highly enriched in the
oligodendrocyte lineage cells (Dugas et al, 2006; Cahoy et al, 2008;
Swiss et al, 2011), is increased during the late phase of differentia-
tion of progenitors into premyelinating oligodendrocytes (Swiss
et al, 2011), and is highly expressed in myelinating cells wrapping
the axons (Cahoy et al, 2008). Interaction partners of GSN include
MAG (myelin-associated glycoprotein), a molecule synthesized in
myelinated oligodendrocytes and localized at the axonal interface
(Trapp et al, 1989; Arroyo & Scherer, 2000); GJB1 encoding the
protein Connexin 32 that localizes in the myelinated fibers of the
central nervous system (Scherer et al, 1995); and SOX10, a key tran-
scriptional regulator of myelination in both central and peripheral
nervous systems (Stolt et al, 2002). The relation of these interaction
partners of GSN and GSN to oligodendrocytes suggests that altera-
tions in the transcriptional programs or composition of oligodendro-
cytes in the prefrontal cortex could be a common feature of AD
and HD.
The aligned subnetwork, consisting of gene pairs commonly
dysregulated in AD and HD in the HBTRC data, overlaps with inde-
pendent AD, HD, and other brain diseases signatures. For instance,
the subnetwork contains 3 AD GWAS or OMIM genes (APOE,
PSEN1, and BIN1, P = 0.0029) and significantly overlaps with genes
known to be upregulated in brain samples from AD patients
(Blalock et al, 2004) (P = 9.5 × 1012). When comparing siRNA
candidates that suppress HTT toxicity in a HD model (Miller et al,
2012), seven of the 147 siRNA candidates represented on our
expression microarray (ASGR1, CAPN2, DAXX, FABP5, RAP1A,
RNF130, and TRPV6) mapped to the subnetwork (P = 0.0027).
Finally, the 242-gene aligned network overlapped with genes
downregulated in postmortem brains of major depressive disorder
patients (P = 5.1 × 1015), which also comprises myelination and
signal transduction-related genes (Aston et al, 2005). These results
together suggest that the aligned subnetwork could underlie
transcriptional disruptions that occur in multiple neural diseases.
Dichotomous dysregulation of two biological processes in the
aligned subnetwork
To glean insights into how the 242-gene aligned subnetwork found
above could underlie multiple brain diseases, we inspected the topo-
logical distribution of the GOC, LOC, and physical interactions
across the network. We observed a surprising LOC/GOC dichotomy
that shed light on the epigenetic dysregulation of oligodendrocyte
differentiation and myelination in AD and HD. We specifically found
that the 151 LOC genes and the 103 GOC genes in this subnetwork
were largely distinct with an overlap of only 12 genes (a LOC gene
is loosely defined as any gene with at least one LOC/green edge and
a GOC gene as any gene with at least one GOC/red edge in Fig 5A),
and these two largely distinct gene groups were connected by
numerous physical interactions (165 of total 370 shown as black
edges in Fig 5A). The inferred dysregulated processes in these
groups revealed an interesting picture: within the whole 242-gene
subnetwork, 33 genes were linked to neuronal differentiation
(P = 8.8 × 107 as seen above), and almost all of them (29) were
LOC genes. When considering only the LOC genes in the subnet-
work, there was even more significant enrichment for neuronal
differentiation genes (P = 1.8 × 109), and for genes regulated
during oligodendrocyte differentiation (Swiss et al, 2011)
(P = 1.02 × 1020). The LOC genes overlapped specifically with
gene clusters that were upregulated in a non-transient fashion
during late stages of oligodendrocyte differentiation
(P = 8.5 × 104, 1.6 × 104, 0.0014, 3.04 × 1010, 2.4 × 104 and
1.2 × 1011, respectively, for clusters 7–12 in (Swiss et al, 2011)).
On the other hand, the GOC genes in the subnetwork, including
GPS2, DNMT1, DNMT3A, YY1, HDAC5, HIST2H3A, and more, were
enriched for GO biological processes negative regulation of gene
expression (P = 1.2 × 107) and chromatin organization
(P = 6.6 × 107) (Fig 5A).
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AB
Figure 3. Overall topology of shared dysregulation in AD and HD.
A, B Topology of the DC network among the AD modules (A) and HD modules (B) reveals a significant enrichment of shared DC pairs in more LOC than GOC modules,
and functional/clinical annotations of several modules. A self-loop edge indicates intra-module DC pairs. The thickness and redness of an edge scales with the
number of aggregated DC pairs and the fraction of these pairs shared between the two diseases, respectively. A module with dark border is significantly
overrepresented for shared intra-module DC pairs (hypergeometric P < 0.05 after Benjamini–Hochberg adjustment for multiple testing), and a module’s color
indicates whether it comprises predominantly GOC (blue) or LOC (red) pairs. Only modules with connections to other modules and edges aggregating at least 20
DC pairs are shown. Any module enriched for a pathway at hypergeometric P < 0.05 (after Bonferroni correction for the pathways tested) is labeled by the most
enriched pathway, and modules enriched for genes correlated to AD Braak stage severity are also labeled.
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Disordered chromatin organization and related epigenetic
mechanisms of histone modifications and DNA methylation are
increasingly appreciated as key pathogenic factors for AD and
HD, but there is still much research to be done for instance in
terms of human studies of DNA methylation changes in AD, as
they are scarce and based only on small cohorts of individuals
(see reviews (Balazs et al, 2011; Coppede`, 2013; Jakovcevski &
Akbarian, 2012)). Our study based on hundreds of human post-
mortem brains provided a unique view, as noted above, of tran-
scriptional dysregulation of chromatin modifier genes (including
methylation-related genes like DNMT1 and DNMT3A) in neurode-
generation and their interconnections in the aligned subnetwork
to oligodendrocyte differentiation genes such as SOX10 and GSN.
Hyper-methylation of the key oligodendrocyte-specific transcrip-
tion factor (TF) SOX10 has been linked to oligodendrocyte
dysfunction (Iwamoto et al, 2005), and we have shown before
that histone modifications of GSN—with a large number of LOC
connections in the subnetwork as noted above—contribute to
oligodendrocyte differentiation in vitro (Liu et al, 2003). We have
also shown that age-dependent histone deacetylation controls
oligodendrocyte differentiation (Shen et al, 2008). All these results
suggest that the 242-gene subnetwork involving two interacting
biological processes, loss of co-regulation in oligodendrocyte
differentiation or myelination and gain of co-regulation in chroma-
tin organization, could underlie multiple neurodegenerative
diseases.
Validating epigenetic regulation of neural differentiation and
DNMT1 as a key regulator in the aligned subnetwork
Among genes involved in chromatin organization in the 242-gene
aligned subnetwork, GPS2 and DNMT1 are top hub genes with 18
and 16 connections within the subnetwork, respectively. GPS2 is a
subunit of the NCOR1–HDAC3 complex, and we have shown that
histone deacetylation controls oligodendrocyte differentiation
(Marin-Husstege et al, 2002; Shen et al, 2008). DNA methylation by
DNMT1 or DNMT3A enzymes has been broadly implicated in neural
development and differentiation (Takizawa et al, 2001; Wu et al,
2010, 2012) as well, but here we aim to validate whether DNA
methylation regulates oligodendrocyte differentiation genes in the
A B
Figure 4. Shared crosstalk between two DC modules reveals a new neurodegenerative association.
A The crosstalk (inter-module) DC relations between AD GOC module M39 and AD LOC module M26 are dominated by the loss of co-regulation of a single gene FAM59B
in M39 with several genes in M26. Note that genes represented by multiple reporters appear more than once in the heatmap.
B Expression of a FAM59B reporter correlates with Braak severity score (P = 0.00095) across all AD and control DLPFC samples (shown as jittered red and blue dots,
respectively).
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242-gene subnetwork disrupted in AD and HD. There are two DNA
methyltransferases, DNMT1 and DNMT3A, in this disease subnet-
work with 16 and 6 interactions, respectively. DNMT1 being one of
the top hub genes with many interaction partners is likely to play a
key regulatory role in the subnetwork, whereas DNMT3A with few
interaction partners is likely to play a smaller role. To test these
predictions, we generated two oligodendrocyte-specific conditional
knockout (CKO) mice, Dnmt1 CKO and Dnmt3a CKO, and dissected
cortices from these brain-specific knockout and respective littermate
control mice for profiling using RNA-seq technology (see Materials
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Figure 5. Physical network links regions of GOC disruption in chromatin organization and LOC disruption in neuronal/oligodendrocyte differentiation.
A, B We systematically aligned the network of common DC pairs detected in both AD and HD with the network of literature-curated physical (protein–protein and
protein–DNA) interactions to obtain a subset of genes that is maximally connected in both networks. This aligned subnetwork is shown in (A), and the immediate
neighborhood of gene GSN in this aligned subnetwork is shown in (B). Red and green edges are, respectively, the GOC and LOC pairs among the common DC pairs,
and black edges mark the physical interactions. Genes with LOC (green) edges were significantly enriched for genes involved in neuronal differentiation (nodes in
orange), and genes with GOC (red) edges were significantly enriched for genes involved in chromatin organization (nodes in red). The node size is proportional to
the number of node’s links in the subnetwork. Dnmt1 brain-specific knockout signature significantly overlaps with the 242-gene subnetwork (A) (P = 3.1 × 1012)
and the immediate neighborhood of gene GSN in this aligned subnetwork (B) (P = 8.4 × 1010). Triangle-shaped nodes with blue borders are genes differentially
expressed in the Dnmt1 brain-specific knockout compared with wild-type littermates.
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and methods). Analysis of this data yielded 388 genes that were
significantly differentially expressed in Dnmt1 CKO mice compared
to their littermate controls at 10% FDR (the Dnmt1 CKO signature),
and 42 genes in the Dnmt3a CKO signature (see Materials and meth-
ods, and Supplementary Datasets D4 and D5). Consistent with our
predictions, the Dnmt1 CKO signature included key oligodendrocyte
differentiation or myelination genes (including the top hub gene
GSN, the TF SOX10, MAG, GJB1, and others discussed above), and
significantly overlapped with the entire disease subnetwork as well
as the GSN local subnetwork (P = 3.1 × 1012 and 8.4 × 1010,
respectively, as shown in Fig 5). Broadly, the Dnmt1 CKO signature
was enriched for genes involved in GO biological processes, nerve
ensheathment, glial cell differentiation, nerve maturation, and lipid
biosynthesis (P-values 1.37 × 1011, 3.4 × 1010, 3.2 × 109, and
7.2 × 109, respectively), again consistent with the biological func-
tions of the subnetwork. Moreover, the Dnmt1 CKO mice showed
increased predilection to seizures, an incidence also increased in
patients with AD (Amatniek et al, 2006) as well as juvenile form of
HD (Cloud et al, 2012). In contrast, the Dnmt3a CKO signature was
much smaller, only marginally overlapped with the subnetwork
(P = 0.017), and was not enriched for any GO biological process.
These results not only validate the interconnection between the two
dysregulated biological processes in the disease subnetwork, but
also validate our key regulator predictions.
Discussion
We show for the first time that the global pattern of gene–gene co-
regulation in the human brain cortex is drastically altered in a
shared fashion in neurodegenerative diseases like AD and HD, by
employing a systematic differential co-expression (DC) analysis that
complements conventional differential expression analysis for find-
ing disease-associated changes. The disrupted DC patterns we found
either can echo reactive responses to the neuronal pathology associ-
ated with neurodegenerative disease or may indicate a direct causal
relationship with the disease. We found that GOC between pairs of
genes was a more dominant feature than LOC in AD and HD. In
contrast, the DC shared between AD and HD showed a larger
proportion of gene pairs that have lost co-expression. This could
suggest a greater role for the LOC-related disruptive changes in the
pathological mechanisms common to both diseases. Moreover,
genes harboring common genetic variants unequivocally found to
be associated with AD were more likely to show LOC, despite GOC
being a more dominant feature among DC genes in AD. This may
indicate that LOC signatures are more likely than GOC genes to be
in causal relationship with the onset and/or progression of the
disease. LOC interactions of genes at the interface between different
DC modules also revealed new candidate disease genes like
FAM59B. Finally, our systematic search for physical interactions
mediating the common DC pairs between AD and HD, besides
revealing extensive molecular alterations involving genes such as
GSN and SOX10 related to oligodendrocyte differentiation, revealed
an interesting split of GOC and LOC dysregulation, respectively, of
two physically inter-connected cellular processes, chromatin organi-
zation and neural differentiation. Results of our two brain-specific
conditional knockout mice validate the interconnection of the two
processes as well as key regulator predictions in the subnetwork.
Aging is linked with multiple neurodegenerative diseases includ-
ing AD and HD. Though most DC patterns identified in the HBTRC
data are distinct from age-associated DC pairs derived from the
aging study (Colantuoni et al, 2011) as seen above, the 242-gene
subnetwork dysregulated in both AD and HD overlaps with DE
signature sets derived from aging brains. For instance, the 242-gene
subnetwork is enriched for genes upregulated in the frontal cortex
of old adults (age 73 or more) when compared with younger cortices
(age 42 or less) (Lu et al, 2004) (P = 2.38 × 1039), but not for age
downregulated genes from the same study (P = 0.27). The enrich-
ments are similar with filtered subsets of these signatures reported
in the aging study using reversed changes in fetal development as a
filter (Supplementary Table S5 of (Colantuoni et al, 2011); enrich-
ment P = 9.6 × 109 versus P = 0.39 for filtered age upregulated
versus downregulated set, respectively). Interestingly, most of the
age upregulated genes in the 242-gene subnetwork participated in
only LOC interactions. Together, these results suggest that aging
may contribute to AD and HD risks by increasing the expression of
certain genes in the aligned subnetwork whose co-regulation
patterns are disrupted in disease.
Comparing molecular and macro-scale networks is not straight-
forward; however, there are studies of both cell function and macro-
scale networks in the human brain which suggest that gain of
co-expression (GOC), a dominant feature in our DC networks, may
indicate increased functional activity. For instance, (1) Buckner et al
2009 used functional neuroimaging (fMRI) to demonstrate that the
human cortex contains hubs of high functional connectivity correlat-
ing with incidence of Ab deposition in AD patients, (2) Ab produc-
tion is strongly stimulated as a function of increasing neuronal
activity (Cirrito et al, 2005), and (3) neuronal activity is highly
increased (50% of the neuronal population) in the vicinity of Ab
plaques in an early-stage AD mouse model (Busche et al, 2008;
Kuchibhotla et al, 2009), with neuronal hyperactive firing in the
cortex combined with an increased astrocyte activity and Ab
plaques. While gain of transcriptional co-regulation in the brain
cortex network may be associated with increased activity surround-
ing misfolded Ab deposits, it is possible that lack of transcriptional
co-regulation (LOC), which is proportionally high in the overlap
between AD and HD and high among genes found to be causally
related to AD, is associated with upstream events that produce or
maintain the misfolded protein aggregates.
Spurious correlations due to systematic noise in the control
samples could result in false positive LOC pairs, especially for genes
with low expression variation between AD/HD and controls (see
also Supplementary Text A.1). However, we showed that the corre-
lation of LOC pairs in our control samples got replicated in an inde-
pendent cohort’s control brain samples. We also showed that genes
implicated in AD in independent GWAS studies predominantly
participated in LOC pairs and modules of genes comprising several
LOC pairs enriched for meaningful biological processes. Further-
more, we verified the robustness of the AD DC network against false
positive errors through replication of both GOC/LOC direction and
magnitude of Q statistics in the independent human cohort. It is
worth noting that exclusion of age-associated DC pairs does not
affect the significance of replication of LOC pairs (P < 1/1,000 using
a permutation test shuffling gene labels), but it increases the replica-
tion P-value of GOC pairs to P < 14/1,000. This result further
supports the importance of LOC pairs in disease pathogenesis.
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Previous studies on differential co-expresssion analysis in AD
have used either module-based (Zhang et al, 2013) or hub-based
(Rhinn et al, 2013) analysis. The module-based analysis defines the
co-expression modules in case and control groups separately before
comparing their correlation structures between the groups, whereas
the hub-based analysis aggregates the differential co-expression of
each gene with all other relevant genes in the transcriptome to prior-
itize disease genes. We take a more direct “edge/pair-based”
approach based on meta-analysis of correlation coefficients to iden-
tify all pairs of genes exhibiting differential co-expression at 1%
FDR. There are several advantages to our edge-based analysis. First,
it enables a direct overlap of the DC networks of multiple diseases
and alignment of the resulting DC network with other types of
networks such as a physical network of protein–protein and
protein–DNA interactions. The 242-gene subnetwork resulting from
this network alignment revealed common molecular mechanisms
underlying AD and HD. Second, our pair-based approach offers a
finer resolution of transcriptional dysregulation that allows us to
inspect DC patterns not only within modules or hubs, but also at the
level of the overall network or at interfaces between two modules.
Indeed, we showed that LOC pairs, which are functionally important
and robustly replicated in the independent dataset, were overall
enriched in the common DC network and arrived at a novel candi-
date disease association FAM59B by inspecting inter-module LOC
pairs.
In summary, this study provides a global view of dysregulatory
networks in AD and HD through integrative analysis of data from
large cohorts of individuals in varying stages of neurodegeneration
and aging. While our study falls short of providing a detailed model
of disease progression due to the non-longitudinal nature of these
datasets, the dysfunctional DC patterns we found in common
between AD and HD, and the supporting physical interactions
connecting dysregulated molecular pathways (available as Supple-
mentary Datasets D1, D2 and D3) significantly advance current
efforts in identifying candidate genes for functional follow-up in
independent clinical sampling and drug discovery efforts, which are
aimed at influencing and/or modifying susceptibility to both neuro-
degenerative diseases.
Materials and Methods
The human brain samples
The HBTRC (Harvard Brain Tissue Resource Center) samples were
primarily of Caucasian ancestry, as only eight non-Caucasian
outliers were identified, and therefore excluded for further analysis.
Postmortem interval (PMI) was 17.8  8.3 h (mean  standard
deviation), sample pH was 6.4  0.3, and RNA integrity number
(RIN) was 6.8  0.8 for the average sample in the overall cohort.
The tissue samples were profiled on a custom-made Agilent 44K
array of 40,638 DNA probes uniquely targeting 39,909 mRNA tran-
scripts of 19,198 known and predicted genes (Supplementary Data-
set D6). Therefore in some cases, transcripts are targeted by more
than one reporter probe, but for ease of notation we refer to these as
genes as any duplicate measures are routinely removed during
subsequent analyses. After extensive quality control of the samples,
624 DLPFC (BA9) brain tissues from AD patients, HD patients, and
non-demented controls (N = 310, 157, and 157, respectively) were
used for further analysis.
Adjustment of the gene expression data
As described earlier (Greenawalt et al, 2011), we used principal
components (PCs) derived from the expression data of the control
probes in the Human 44k v1.1 array to adjust the expression data
of the other probes, in order to mitigate the effect of unknown
confounding factors (Gagnon-Bartsch & Speed, 2012). This adjust-
ment was done in a linear regression setting using the selected PCs
as covariates. Following the earlier method (Greenawalt et al,
2011), we selected as covariates the 1st PC from r60 control
probes, the 1st PC from Pro25G control probes, and the PCs of all
remaining control probes that had variance explained at P < 1e–04
when compared to a randomized version (obtained from 10,000
permutations of the original data, with each control probe
permuted independently). The resulting control-probes-adjusted
expression data were further adjusted for several factors that could
potentially confound the differences between normal and AD/HD
datasets. These adjusted covariates include age, gender, RIN, pH,
PMI, batch, and preservation of the samples. Specifically, a robust
linear regression model of each gene’s expression data was fitted
separately for the AD, HD, and control group using these covari-
ates, and residues from the fitted models were taken as the
adjusted data for further analyses (rlm in R library MASS with
Huber bisquare proposal was used to fit the model). The missing
expression values in all expression datasets used in this
study, including external datasets, were imputed using the
k-nearest neighbors algorithm in the space of genes with k = 10
(Troyanskaya et al, 2001).
Genotyping and association testing of disease SNPs
Each subject was genotyped on two different platforms, the Illumina
HumanHap650Y array (IL650) and a custom Perlegen 300K array (a
focused panel for detection of singleton SNPs; PL300). Counting
only the union of markers from both genotyping platforms (114,925
SNPs were in the intersection), a total of 838,958 unique SNPs were
used for analysis. Restriction Fragment Length Polymorphism
(RFLP) was used to genotype the APOE polymorphisms in the
HBTRC samples as described earlier (Gioia et al, 1998). Briefly, the
initial PCR yields an amplicon of 485 bp of APOE exon 4 containing
both polymorphisms, following a nested PCR product of 300 bp.
HhaI digestion of the nested amplicon generated unique patterns of
restriction fragments depending on the original genotype of the indi-
vidual (Gioia et al, 1998). The GAB2 SNP rs2373115 (Reiman et al,
2007) was not present on the arrays and was therefore genotyped
using a TaqMan assay. The single point association testing of APOE
genotypes and other SNPs (reported in Supplementary Table S2) was
carried out in the R statistical environment using a logistic regression
model encoded by the R formula: disease_status ~ logistic
(b0 + b1 × (count of minor allele) + b2 × age + b3 × gender). The
disease SNP P-value indicates how significantly different b1 is from
0. The OR estimate was calculated from exp(b1). We applied
the following quality control filters to retain only SNPs that have
MAF (Minor Allele Frequency) > 0.05, HWE (Hardy–Weinberg
Equilibrium) test P-value > 10e–06, and SNP call rate > 0.90.
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Meta-analysis of gene–gene correlation
We used a parametric meta-analysis method to test for changes in
gene–gene correlation between two groups (e.g., disease versus
controls), under the assumption that gene pairs are bivariate
normally distributed in each group. This method yielded similar
results as (and somewhat more conservative P-values than) a
bootstrap method with no parametric assumptions, on a random
subset of gene pairs in our data (see Supplementary Fig S7 for
these results and a description of the bootstrap method, which is
computationally intensive even on a subset of all gene pairs). We
now describe the parametric method: for each gene pair (i,j) and
their Spearman correlation coefficients rtij (with t = 1 and 2
computed in disease and control samples, respectively), we first
transformed the correlation coefficients into Fisher’s Z-statistics
ztij ¼ 12 log 1þrtij1rtij
 
, which follows a normal distribution with zero
mean and standard deviation of 1ffiffiffiffiffiffiffiffi
nt3
p (nt is the sample size) under
our parametric assumption of bivariate normality. A heterogeneity
statistic Q is then computed for each gene pair as shown next
(without the i,j subscripts for clarity): Q ¼Pt wtðzt  zÞ2 with the
weights wt = nt  3 being used to also compute z as the weighted
average of the z in the disease and the control group. The Q
statistic follows a v2 distribution with one degree of freedom
under homogeneity and parametric assumptions (Hedges & Olkin,
1985), and the larger it is, the less similar the gene–gene correla-
tion is between the two groups. To make differential co-expression
calls from the Q statistics of all gene pairs taken together, we used
a global permutation-based approach that both accounts for
multiple testing and is robust to any violations of parametric
assumptions (Storey & Tibshirani, 2003). We specifically permuted
the original data once (by randomly assigning sample labels to
shuffle the two groups together) and repeated the meta-analysis
procedure. Then for any global cutoff value Q0, we take the ratio
of the number of gene pairs that had Q > Q0 in the permuted to
the original data as the estimated global FDR (false discovery rate)
at this cutoff. The final cutoff we chose corresponding to FDR 1%
translates to: Q0 = 25.6 for AD versus controls comparison, and
Q0 = 21.7 for HD versus controls comparison. Unless specified
otherwise, in addition to requiring a gene pair to have Q > Q0, the
pair has to be significantly co-expressed in either the disease or
the control group of samples (but not both) to be called as a
differentially co-expressed or DC pair. The GOC and LOC category
of DC pairs is defined based on which group the gene pair is
significantly co-expressed. We call a pair as significantly co-
expressed in a group of samples if their Spearman’s correlation
test P-value is at most 0.01 after correction for the all reporter–
reporter tests among the 40,638 reporters, and not significantly co-
expressed otherwise.
Independent human cohorts used in replication testing
We tested replication of the DC pairs identified using the HBTRC
samples in an independent human cohort of late-onset AD and
control individuals (Webster et al, 2009). We obtained the expres-
sion data of that study from GEO (GSE15222), extracted the data of
postmortem frontal cortex samples alone of 31 AD and 40 control
individuals (over 24,354 transcripts, which became 23,613 unique
transcripts after replacing transcripts represented by multiple
probes with a randomly pre-selected probe), and adjusted through
a linear regression model the AD and control group data separately
for the same set of covariates used in the study. To dissect the
contribution of aging to differential co-expression, we used another
independent human dataset comprising expression data of neuropa-
thology-free postmortem prefrontal cortex samples (Colantuoni
et al, 2011) of 56 elder (age between 50 and 90 at time of death)
and 53 adult (age between 20 and 40 at time of death) individuals.
We obtained the preprocessed expression data of that study from
GEO (GSE30272) before SVA (Surrogate Variable Analysis) adjust-
ment, extracted the data of the elder and adult group of individuals
alone, and adjusted through a linear regression model each group’s
data separately for all non-SVA covariates reported in the study
(with the exception of ‘smoking history’ as this covariate was
highly correlated to and had more missing data than the ‘smoke at
death’ covariate).
Identification of modules in the DC transcriptional network
We used our previously published clustering method described in
detail in Wang et al (2009). Briefly, the method uses spectral tech-
niques to derive a clustering tree from the DC network obtained
from AD versus controls or HD versus controls comparison, and
modularity score as an objective function to parse the clustering tree
into modules or clusters (of size at least 10 and at most 100) that
contain more DC interactions than expected from a random model.
The modules were numbered based on their modularity scores, with
M1 being the module with the highest modularity score in the
network, M2 being the next highest, and so forth. The enrichment
P-values used for pathway enrichment were calculated using a
hypergeometric distribution. All DC modules were tested for enrich-
ment of functional annotations and all significant enrichments
(P ≤ 0.05 after Bonferroni correction for the number of Ingenuity
Pathways tested) are reported (but for a module showing multiple
significant enrichments, only the best one is reported).
Alignment of physical interaction network and common
DC network
Since large-scale collections of published physical (protein–protein
and protein–DNA) interactions are not yet sufficiently comprehen-
sive (Mathivanan et al, 2006), we aligned the physical network
(viewed as undirected network after dropping edge orientations)
with the network of common DC pairs identified in both diseases
using a method that is more robust than simply overlapping the
edges in the two networks. This alignment method specifically sets
out to find all maximal subsets of genes that are connected in both
the physical network and the common DC network. Maximal
subsets of genes that are connected in two given networks can be
found recursively using a simplified variant of a provably efficient
algorithm, Match-and-Split, which we have developed previously
(Narayanan & Karp, 2007). This variant would find all connected
components in the first network, and for each such component,
output them if they are also connected in the second network or
split them into further connected components in the second network
otherwise. This process is repeated recursively until all components
of a certain minimum size (10 genes) that are connected in both
networks are found.
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Dnmt1 and Dnmt3a brain-specific conditional
knockout experiments
All of the mice used in this study were handled in accordance with
IACUC-approved protocols. Dnmt1flox/flox (Fan et al, 2001; Jackson-
Grusby et al, 2001) and Dnmt3aflox/flox (Nguyen et al, 2007) mice
were backcrossed onto a C57BL/6 background and crossed with
Olig1-cre mice to generate Dnmt1 conditional knockout (Olig1cre/+;
Dnmt1flox/flox) and littermate control (Olig1+/+;Dnmt1flox/flox) mice,
and Dnmt3a conditional knockout (Olig1cre/+;Dnmt3aflox/flox) and
littermate control (Olig1+/+;Dnmt3aflox/flox) mice. Cortices were
dissected from Dnmt1 conditional knockout (CKO), Dnmt3a CKO,
and respective littermate control mice at postnatal day 16. Dnmt1 and
Dnmt3a were knocked out in oligodendrocytes specifically (Supple-
mentary Fig S8) with recombination rate over 70% (Zhang et al,
2009). RNA was isolated from three biological replicates for each
genotype using TRIzol (Invitrogen) extraction and isopropanol
precipitation. RNA samples were resuspended in water and further
purified with RNeasy columns with on-column DNase treatment
(Qiagen). RNA purity was assessed by measuring the A260/A280
ratio using a NanoDrop and RNA quality checked using an Agilent
2100 Bioanalyzer (Agilent Technologies). Approximately 250 ng of
total RNA per sample were used for library construction by the
TruSeq RNA Sample Prep Kit (Illumina) and sequenced using the Illu-
mina HiSeq 2500 instrument according to the manufacturer’s instruc-
tions. Sequence reads were aligned to the mouse genome (assembly
mm10) and gene expression quantified using Tophat/Cufflinks meth-
ods, and differentially expressed genes at FDR 10% (Q-value < 0.1)
were identified using Cuffdiff (Trapnell et al, 2013). To compare gene
signatures of mouse experiments with human networks, we used
human–mouse gene orthologs provided by The Jackson Laboratory
(http://www.informatics.jax.org/homology.shtml).
Data availability
Gene expression data of the human brain samples used in this study
are available at the GEO public database under the accession
number GSE33000.
Gene expression data from the mouse conditional knockout
experiments are also publicly available under the GEO accession
number GSE58261.
Supplementary information for this article is available online:
http://msb.embopress.org
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